Your Health Plan:
TRESIBA (insulin degludec) is a biologic prescription drug for treatment of Diabetes Mellitus. TRESIBA is a insulin analog. It is available in the form of subcutaneous injection.
See full Prescribing Information for important safety information and clinical studies.
TRESIBA is not covered by . Cash price for 30-day supply is $400-845.
Patient Assistance Prorgams and Coupons are found:
Other alternatives to TRESIBA may include:
